Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019
Tingyan Wang, David A. Smith, Cori Campbell, Steve Harris, Hizni Salih, Kinga A. Várnai, Kerrie Woods, Theresa Noble, Oliver Freeman, Zuzana Moysova, Thomas Marjot, Gwilym J. Webb, Jim Davies, Eleanor Barnes, Philippa C. Matthews – 29 April 2021 – The association of liver biochemistry with clinical outcomes of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is currently unclear, and the utility of longitudinally measured liver biochemistry as prognostic markers for mortality is unknown.